Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
1.500
-0.020 (-1.32%)
At close: Sep 10, 2026, 4:00 PM EDT
1.470
-0.030 (-2.00%)
After-hours: Sep 10, 2026, 7:48 PM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $152.44 million as of September 10, 2026. Its market cap has decreased by -30.29% in one year.
Market Cap
152.44M
Enterprise Value
108.49M
1-Year Change
-30.29%
Ranking
Category
Stock Price
$1.50
ChartMarket Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $152.44M, a decrease of -79.57%. That is a compound annual growth rate of -26.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 152.44M | -26.13% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | -26.92% |
| Jul 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuronetics | 229.35M |
| Electromed | 222.96M |
| Quantum-Si incorporated | 161.78M |
| Lucid Diagnostics | 153.54M |
| Inogen | 137.47M |
| Owlet | 137.05M |
| MaxCyte | 122.82M |
| Apyx Medical | 121.74M |